Skip to main content

Pathologic Aspects of Ischemic Limb Disease

  • Chapter
  • First Online:
Critical Limb Ischemia

Abstract

Ischemia of the extremities is a fairly common clinical entity most commonly caused by occlusive arteriosclerotic disease with secondary thrombosis or embolization. The resultant ischemic extremity will present with progressive pain syndromes and pregangrenous or gangrenous tissue. When the disease progresses beyond survivability and the symptomatology is unbearable, amputation is necessitated. The pathologist then receives the premorbid or neurotic tissue after removal.

Other diseases, besides the arteriosclerotic occlusions, are seen on occasion producing severe limb ischemia. Raynaud’s disease, Buerger’s disease (thromboangiitis obliterans), and Behcet’s disease are lesser causes for these changes as well as coagulation abnormalities. Even embolic syndromes due to tumor, foreign bodies, or thrombus at surgery may be present in addition to Heyde’s syndrome secondary to aortic valve disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roscher AA, Kato NS, Quan H, Padmanabham M. Intra-atrial myxomas, clinical pathologic correlation based on two case studies, including historical review. J Cardiovasc Surg (Torino). 1996;37(6 suppl 1):131–7.

    CAS  Google Scholar 

  2. Stamler J. Cardiovascular diseases in the United States. Am J Cardio. 1962;10:319.

    Article  CAS  Google Scholar 

  3. Endlich HL, Roscher AA. Current concepts in the study of the aortic arch and brachiocephalic vessels: a clinical and pathologic study of 300 cases, including surgical results. Twelfth Int Coll Radio. Tokyo, Japan, October 1969.

    Google Scholar 

  4. Endlich HL, Roscher AA. Current concepts in the study of the aortic arch and brachiocephalic bessels: a clinical and pathologic study of 300 cases, including surgical results. Int Surg. 1971;55(1):32–41.

    Google Scholar 

  5. Dimmick DJ, Goho AC, Cauzze-Steinbach LS, Baumgartner I, Stausser E, Voelgelin E, Anderson SE. Imaging appearances of Buerger’s disease complications in the upper and lower limbs. Clin Radiol. 2012;67(12):1207–11.

    Google Scholar 

  6. Millikan GH. Pathogenesis of transient focal cerebral ischemia. The Lewis A. Conner Memorial Lecture. Circulation. 1965;32:438–50.

    Article  CAS  PubMed  Google Scholar 

  7. Tanaka K. Pathology and pathogenesis of Buerger’s disease (TAO). Int J Cardiol. 1998;66:S237–42.

    Article  PubMed  Google Scholar 

  8. Dellalibera-Joiliana R, Joiliana EE, Silva JS, Evora PR. Activation of cytokines corroborates with development of inflammation and autoimmunity within thromboangiitis obliterans in patients. Clin Exp Immunol. 2012;170(1):28–35.

    Google Scholar 

  9. Lozarides MK, Georgiadis GS, Pappas TT, Nizolopoulos ES. Diagnostic criteria and treatment of Buerger’s disease with review. Int J Low Extrem Wounds. 2006;5(2):89–95.

    Google Scholar 

  10. Moon IS. Abdominal aortic aneurysm repair in post kidney transplanted patients: in eleven cases of Bechet’s disease. ICS World Congress. Quito, Ecuador. Oct 6–10, 2004 (page 75 of Program Booklet).

    Google Scholar 

  11. Goa KL, Henwood JN, Stolz KS, Langley MS, Clissold SP. Intravenous Streptokinase – a reappraisal of its therapeutic use in acute myocardial infarction. Drugs. 1990;39(5):693–719.

    Google Scholar 

  12. Nakagami H. Autologous cell therapy in ischemic limb disease. Dept of Gene Science Therapy, Osaka University Graduate School of Medicine. 2. 2 Yamada Osa Suite 565–0871 (Published statement) Japan.

    Google Scholar 

  13. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy – associated thrombosis. Blood. 2008;111(10):4902–7.

    Google Scholar 

  14. Dieter Jr RA, Kuzycz GK, Dieter III RA, Dieter RS. The ORC patient/tumor classification – a new approach: a new challenge with special consideration for the lung. J Cancer Ther. 2011;2(2):172–5.

    Article  Google Scholar 

  15. Paxyon A. Coag quest: keying into the clot risk of cancer patients. CAP Today. 2015:(1);1–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Roscher, A.A., Dieter, R.A., Johnson, B.L. (2017). Pathologic Aspects of Ischemic Limb Disease. In: Dieter, R., Dieter, Jr, R., Dieter, III, R., Nanjundappa, A. (eds) Critical Limb Ischemia. Springer, Cham. https://doi.org/10.1007/978-3-319-31991-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31991-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31989-6

  • Online ISBN: 978-3-319-31991-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics